Home Page

Insurers and the government are scrutinizing laboratory billing arrangements where small, financially challenged hospitals contract with Medical Service Organizations (MSO) to perform laboratory marketing servi...

Clinical laboratories large and small are experiencing increased scrutiny from the federal government, states and private insurers.  This focus has developed because payers have identified several areas in whic...

Listen to Dr. John Daly, Chief Medical Officer (CMO) for COLA discuss the use of a popular molecular technology called liquid biopsy in laboratories. https://www.youtube.com/watch?v=OpqqUp8pw9g...

Rabies is a disease caused by an RNA virus transmitted from infected carnivores and bats.  While the incidence and epidemiology have changed in the US over the past 75 years, occasional human cases still occur ...

Candida auris is an emerging fungus which CDC has indicated presents a potential global threat.  Candida auris was originally identified in Japan in 2009 and in the ensuing 8 years has been identified in multip...